BIBLIOGRAFIA SUI DANNI DA VACCINI - MEDNAT.org

Del Giudice G, Pizza M, Rappuoli R. Mucosal delivery of vaccines. Methods 1999;148­55.
Desselberger U. Rotavirus infections: guidelines for treatment and prevention. Drugs 1999;447­52.
Deuson RR, Hoekstra EJ, Sedjo R, Bakker G, Melinkovich P, Daeke D, Hammer AL, Goldsman D, Judson FN. The Denver school­based adolescent hepatitis
B vaccination program: a cost analysis with risk simulation. Am.J.Public Health 1999;1722­7.
Diego Nunez MA, Gonzalez Menendez AE. Vaccination against hepatitis B and multiple sclerosis. An Esp Pediatr. 1999 Jan;50(1):97.
Dille JH. A worksite influenza immunization program. Impact on lost work days, health care utilization, and health care spending. AAOHN.J. 1999;301­9.
Dille JH. Worksite influenza immunization. Successful program. AAOHN.J. 1999;292­300.
Dlugovitzky D, Bottasso O, Dominino JC, Valentini E, Hartopp R, Singh M, Stanford C, Stanford J. Clinical and serological studies of tuberculosis patients in
Argentina receiving immunotherapy with Mycobacterium vaccae (SRL 172). Respir.Med. 1999;557­62.
Dodson SF, Bonham CA, Geller DA, Cacciarelli TV, Rakela J, Fung JJ. Prevention of de novo hepatitis B infection in recipients of hepatic allografts from
anti­HBc positive donors. Transplantation 1999;1058­61.
Dolan TT. Dogmas and misunderstandings in East Coast fever. Trop.Med.Int.Health 1999;A3­11.
Dolo A, Modiano D, Doumbo O, Bosman A, Sidibe T, Keita MM et al. Thrombospondin related adhesive protein (TRAP), a potential malaria vaccine
candidate. Parassitologia 1999; 41(1­3):425­428.
Drabick JJ, Brandt BL, Moran EE, Saunders NB, Shoemaker DR, Zollinger WD. Safety and immunogenicity testing of an intranasal group B meningococcal
native outer membrane vesicle vaccine in healthy volunteers. Vaccine 1999;160­72.
Dranoff G. Interpreting cancer vaccine clinical trials. J Gene Med 1999; 1(2):80­83.
Drobeniuc J, Hutin YJ, Harpaz R, Favorov M, Melnik A, Iarovoi P, Shapiro CN, Woodruff BA. Prevalence of hepatitis B, D and C virus infections among
children and pregnant women in Moldova: additional evidence supporting the need for routine hepatitis B vaccination of infants. Epidemiol.Infect.
1999;463­7.
Dunn C, Wilde M, Paterson R. Agents in development for the treatment of hepatitis C. Summary and table. Drugs R.D. 1999;259­64.
Edmunds WJ, Medley GF, Nokes DJ. Evaluating the cost­effectiveness of vaccination programmes: a dynamic perspective. Stat.Med. 1999;3263­82.
Effect of subclinical infection on maintaining immunity against measles in vaccinated children in West Africa. The Lancet, vol. 353, January 9, 1999, pp. 98­
102.
Ellett ML. Hepatitis A, B, and D. Gastroenterol Nurs 1999 Nov­1999 Dec 31;22(6):236­44.
Encke J, zu PJ, Wands JR. DNA vaccines. Intervirology 1999;117­24.
Enjuanes L, Sola I, Izeta A, Sanchez­Morgado JM, Gonzalez JM, Alonso S et al. Interference with virus and bacteria replication by the tissue specific
expression of antibodies and interfering molecules. Adv Exp Med Biol 1999; 473:31­45.
Erdmann C. Child immunization. Stuck on service [news]. Hosp.Health Netw. 1999;22, 24.
Esmaeli­Gutstein B, Winkelman JZ. Uveitis associated with varicella virus vaccine. Am J Ophthalmol 1999 Jun;127(6):733­4.
Evans AA, London WT. Hepatitis B vaccine and liver problems in U.S. children less than 6 years old [letter]. Epidemiology 1999;790­1.
Exp Clin Endocrinol Diabetes. 1999;107 Suppl 3:S93­100.
Fagerberg J, Askelof P, Wigzell H, Mellstedt H. Induction of CD4(+) and CD8(+) Bordetella pertussis toxin subunit S1 specific T cells by immunization with
synthetic peptides. Cell Immunol. 1999;110­21.
Feder HM, Jr., Beran J, Van Hoecke C, Abraham B, De Clercq N, Buscarino C, Parenti DL. Immunogenicity of a recombinant Borrelia burgdorferi outer
surface protein A vaccine against Lyme disease in children [see comments]. J.Pediatr. 1999;575­9.
Fedson DS. Pneumococcal vaccination for older adults: the first 20 years. Drugs Aging 1999; 15 Suppl 1:21­30.
Feldman C. Pneumonia in the elderly. Clin.Chest Med. 1999;563­73.
Feng H, Sandlow JI, Sparks AE, Sandra A. Development of an immunocontraceptive vaccine. Current status. J.Reprod.Med. 1999;759­65.
Fenner F. Nature, nurture and my experience with smallpox eradication. Med J Aust 1999; 171(11­12):638­641.
Fernandez S, Arreaza L, Santiago I, Malvar A, Berron S, Vazquez JA, Hervada X, Gestal JJ. Carriage of a new epidemic strain of Neisseria meningitidis and
its relationship with the incidence of meningococcal disease in Galicia, Spain. Epidemiol.Infect. 1999;349­57.
Findley SE, Irigoyen M, Schulman A. Children on the move and vaccination coverage in a low­income, urban Latino population. Am.J.Public Health
1999;1728­31.
Fiore AE, Levine OS, Elliott JA, Facklam RR, Butler JC. Effectiveness of pneumococcal polysaccharide vaccine for preschool­age children with chronic
disease. Emerg.Infect.Dis. 1999;828­31.
Flanagan JR, Doebbeling BN, Dawson J, Beekmann S. Randomized study of online vaccine reminders in adult primary care. Proc.AMIA.Symp. 1999;755­9.
Flanagan JR, Walker KP. Tracking vaccine compliance in a primary care setting: online history, reminders, order entry, and charting. Proc.AMIA.Symp.
1999;760­4.
Fledelius HC. Unilateral papilloedema after hepatitis B vaccination in a migraine patient. A case report including forensic aspects. Acta Ophthalmol.Scand.
1999;722­4.
Flynn JT, Frisch K, Kershaw DB, Sedman AB, Bunchman TE. Response to early measles­mumps­rubella vaccination in infants with chronic renal failure and/
or receiving peritoneal dialysis. Adv Perit Dial 1999; 15:269­272.
Ford­Jones A. Practice Tips. Immunization tracker for primary care physicians. Can.Fam.Physician 1999;2875­6.
Forleo­Neto E, de Oliveira CF, Maluf EM, Bataglin C, Araujo JM, Kunz Jr LF, Pustai AK, Vieira VS, Zanella RC, Brandileone MC, Mimica LM, Mimica IM.
Decreased point prevalence of Haemophilus influenzae type b (Hib) oropharyngeal colonization by mass immunization of Brazilian children less than 5
years old with hib polyribosylribitol phosphate polysaccharide­tetanus toxoid conjugate vaccine in combination with diphtheria­tetanus toxoids­pertussis
vaccine. J.Infect.Dis. 1999;1153­8.
Freedman DA, Stark PB. The swine flu vaccine and Guillain­Barre syndrome. A case study in relative risk and specific causation. Eval Rev 1999
Dec;23(6):619­47.
Freis PC. DNA vaccines [letter]. N.Engl.J.Med. 1999;1623­4.
Frick KD, Simonsick EM. SES, Medicare coverage, and flu shot utilization among vulnerable women in the women's health and aging study.
Ann.N.Y.Acad.Sci. 1999;493­6.
Gabrieli R, Divizia M, El Ghazzawi E, Kader OA, El Gawhary Z, Renganathan E, Pana A. Serum antibodies to polioviruses in Alexandria, Egypt.
Eur.J.Epidemiol. 1999;267­70.
Gardner MJ, Tettelin H, Carucci DJ, Cummings LM, Smith HO, Fraser CM et al. The malaria genome sequencing project: complete sequence of Plasmodium
falciparum chromosome 2. Parassitologia 1999; 41(1­3):69­75.
Gardner P. Indications for acellular pertussis vaccines in adults: the case for selective, rather than universal, recommendations. Clin.Infect.Dis. 1999;S131­
S135.
Garrity RR. Targeted immune design using RNA immunization. Ann.N.Y.Acad.Sci. 1999;124­9.
Gelbart M. Measles: the child slayer. Nurs Times 1999 Nov 3­1999 Nov 9;95(44):46­7.
Gelbart M. Polio strikes back. Nurs.Times 1999;24­6.
Gelbart M. Whooping cough: how the west was won. Nurs Times 1999; 95(40):52­54.
Gelbart, M. Influenza: the mutating assassin waiting to strike. Nurs Times 1999 Nov 10­17;95(45):52­3
Gharavi EE, Chaimovich H, Cucurull E, Celli CM, Tang H, Wilson WA, Gharavi AE. Induction of antiphospholipid antibodies by immunization with
synthetic viral and bacterial peptides. Lupus 1999;449­55.